Technical standards and guidelines for fragile X: the first of a series of disease-specific supplements to the Standards and Guidelines for Clinical Genetics Laboratories of the American College of Medical Genetics. Quality Assurance Subcommittee of the Laboratory Practice Committee

Genet Med. 2001 May-Jun;3(3):200-5. doi: 10.1097/00125817-200105000-00010.

Abstract

Preface:: The Quality Assurance subcommittee of the ACMG Laboratory Practice committee has the mission of maintaining high technical standards for the performance and interpretation of genetic tests. In part, this is accomplished by the publication of the document “Standards and Guidelines for Clinical Genetics Laboratories,” which was published in its second edition in 1999 and is now maintained online (see www.faseb.org/genetics/acmg/index.html). This subcommittee also reviews the outcome of national proficiency testing in the genetics area and may choose to focus on specific diseases or methodologies in response to those results. Accordingly, the subcommittee selected fragile X syndrome to be the first topic in a new series of supplemental sections, recognizing that it is one of the most frequently ordered genetic tests and that it has many alternative methods with different strengths and weaknesses. This document follows the outline format of the general Standards and Guidelines. It is designed to be a checklist for genetic testing professionals who are already familiar with the disease and the methods of analysis.

MeSH terms

  • Blotting, Southern
  • Family Health
  • Female
  • Fragile X Syndrome / diagnosis*
  • Fragile X Syndrome / genetics*
  • Genetic Linkage*
  • Genetic Testing
  • Genetics*
  • Guidelines as Topic
  • Humans
  • Male
  • Mutation
  • Polymerase Chain Reaction
  • United States
  • X Chromosome*